Pancreatic Adenocarcinoma — Trials

Pancreatic Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 357
Recruiting: 209
Ph III recruiting: 23
Growth YoY: +36.1%
Industry share: 41%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (136)

clinicaltrialsPublishedShowing 251–300 of 916 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04789486	Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer	recruiting	Phase 1 / Phase 2	100	Dana-Farber Cancer InstituteOTHER	1	May 14, 2026	clinicaltrials
NCT05988918	Multicenter Trial of ESK981 in Patients With Select Solid Tumors	active not recruiting	Phase 2	17	University of Michigan Rogel Cancer CenterOTHER	1	May 14, 2026	clinicaltrials